FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma.
Adolescent
Adult
Aged
Aged, 80 and over
Disease-Free Survival
Female
Glucose-6-Phosphate
/ administration & dosage
Helicobacter Infections
/ diagnostic imaging
Helicobacter pylori
Humans
Lymphoma, B-Cell, Marginal Zone
/ diagnostic imaging
Male
Middle Aged
Positron-Emission Tomography
Predictive Value of Tests
Retrospective Studies
Survival Rate
FDG-PET/CT
SUV
marginal zone lymphoma
prediction
prognosis
Journal
Hematological oncology
ISSN: 1099-1069
Titre abrégé: Hematol Oncol
Pays: England
ID NLM: 8307268
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
21
12
2018
revised:
28
01
2019
accepted:
04
02
2019
pubmed:
9
2
2019
medline:
8
5
2019
entrez:
9
2
2019
Statut:
ppublish
Résumé
We evaluated the role of 18-fluoro-2-deoxy-d-glucose positron emission tomography (
Substances chimiques
2-fluoro-2-deoxyglucose-6-phosphate
40871-47-4
Glucose-6-Phosphate
56-73-5
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
168-175Informations de copyright
© 2019 John Wiley & Sons, Ltd.